Boceprevir.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 00126667 AND DT 2012 AND VI 72 AND IP 18
Results: 11
1
2
Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
3
Ingenol Mebutate Gel 0.015% and 0.05%.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
4
Adalimumab.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
5
US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
6
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
7
Optimal Use of Treprostinil in Pulmonary Arterial Hypertension.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
8
Axitinib.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
9
Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
10
Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
11
Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™).
- Published in:
- Drugs, 2012, v. 72, n. 18, p. 2407, doi. 10.2165/11209580-000000000-00000
- By:
- Publication type:
- Article